PCSK9 Inhibition to Reduce Cardiovascular Events
- PMID: 28304233
- DOI: 10.1056/NEJMe1703138
PCSK9 Inhibition to Reduce Cardiovascular Events
Comment on
-
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304224 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous